93 related articles for article (PubMed ID: 6752059)
1. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
[TBL] [Abstract][Full Text] [Related]
2. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
[TBL] [Abstract][Full Text] [Related]
3. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
[TBL] [Abstract][Full Text] [Related]
4. Decreased insulin removal contributes to hyperinsulinemia in obesity.
Faber OK; Christensen K; Kehlet H; Madsbad S; Binder C
J Clin Endocrinol Metab; 1981 Sep; 53(3):618-21. PubMed ID: 7021583
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
7. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
[TBL] [Abstract][Full Text] [Related]
9. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
[TBL] [Abstract][Full Text] [Related]
11. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
12. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity.
Jimenez J; Zuniga-Guajardo S; Zinman B; Angel A
J Clin Endocrinol Metab; 1987 Apr; 64(4):661-8. PubMed ID: 3546350
[TBL] [Abstract][Full Text] [Related]
13. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
14. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Lefebvre PJ; Torella R
J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
[TBL] [Abstract][Full Text] [Related]
15. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
16. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
[No Abstract] [Full Text] [Related]
17. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
[TBL] [Abstract][Full Text] [Related]
18. The effect of single-dose orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients.
Sahin M; Tanaci N; Yucel M; Tutuncu NB; Guvener N
Clin Endocrinol (Oxf); 2007 Sep; 67(3):346-50. PubMed ID: 17524030
[TBL] [Abstract][Full Text] [Related]
19. Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
Vasquez B; Nagulesparan M; Unger RH
Horm Metab Res; 1983 May; 15(5):218-20. PubMed ID: 6347855
[TBL] [Abstract][Full Text] [Related]
20. [Increase of circulating levels of insulin and C-peptide: common factors in essential hypertension and overweight].
Sechi LA; Tedde R; Melis A; Pala A; Marigliano A; Orecchioni C; Pisanu G; Bartoli E
Ann Ital Med Int; 1990; 5(4 Pt 1):348-52. PubMed ID: 2093360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
